Products Categories
| CAS No.: | 74050-97-8 |
|---|---|
| Name: | 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidyl decanoate |
| Molecular Structure: | |
|
|
|
| Formula: | C31H41ClFNO3 |
| Molecular Weight: | 530.123 |
| Synonyms: | Haldoldecanoate;Halomonth;KD 136;KD 16;Neoperidole;R13762; |
| EINECS: | 277-679-7 |
| Density: | 1.14 g/cm3 |
| Melting Point: | 326.1 °C |
| Boiling Point: | 615.5 °C at 760 mmHg |
| Flash Point: | 326.1°C |
| PSA: | 46.61000 |
| LogP: | 8.05510 |
- 81281-59-67-Benzylideneaminotheophylline
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 852475-26-4MC1568
- 958254-66-51H-Imidazo[4,5-b]pyridine-2-carboxaldehyde, 1-methyl-, hydrochloride
- 99170-93-1N-Methyl-2-oxazolamine
- 914458-26-7[5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-Methanone
- 894852-01-87-BROMO-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE
- 90221-55-92-bromo-5-methylbenzaldehyde
- 885590-99-82,3-DIFLUORO-4-IODOBENZALDEHYDE
- 97730-31-9(S)-4'-(2-Methylbutyl)Biphenyl-4-Carbonitrile
- Total:38 Page 1 of 1 1
What can I do for you?
Get Best Price
Chemistry
Molecular structure of Haloperidol decanoate (CAS NO.74050-97-8) is:
Product Name: Haloperidol decanoate
CAS Registry Number: 74050-97-8
IUPAC Name: [4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl]decanoate
Molecular Weight: 530.113543 [g/mol]
Molecular Formula: C31H41ClFNO3
XLogP3: 7.9
H-Bond Donor: 0
H-Bond Acceptor: 5
EINECS: 277-679-7
Surface Tension: 46.6 dyne/cm
Density: 1.14 g/cm3
Flash Point: 326.1 °C
Enthalpy of Vaporization: 91.32 kJ/mol
Boiling Point: 615.5 °C at 760 mmHg
Vapour Pressure: 4.38E-15 mmHg at 25 °C
Product Categories: Organics
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | intramuscular | > 1gm/kg (1000mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985. |
| mouse | LD50 | intramuscular | > 3500mg/kg (3500mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985. |
| mouse | LD50 | intraperitoneal | 288mg/kg (288mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985. |
| mouse | LD50 | oral | 739mg/kg (739mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985. |
| mouse | LD50 | subcutaneous | 1990mg/kg (1990mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985. |
| rat | LD50 | intramuscular | > 1525mg/kg (1525mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985. |
| rat | LD50 | intraperitoneal | 328mg/kg (328mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985. |
| rat | LD50 | oral | 1717mg/kg (1717mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985. |
| rat | LD50 | subcutaneous | 780mg/kg (780mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985. |
| women | TDLo | intravenous | 11600ug/kg/4D (11.6mg/kg) | CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE CARDIAC: CHANGE IN RATE | Annals of Internal Medicine. Vol. 119, Pg. 391, 1993. |
Safety Profile
Poison by intraperitoneal route. Moderately toxic by ingestion, subcutaneous, and intramuscular routes. An experimental teratogen. Other experimental reproductive effects. Human systemic effects: arrhythmias, EKG changes, heart rate changes. When heated to decomposition it emits toxic fumes of F−, Cl−, and NOx.
RIDADR: 3249
HazardClass: 6.1(b)
PackingGroup: III
Specification
Haloperidol decanoate , its cas register number is 74050-97-8. It also can be called Haloperidol decanoate [USAN:BAN:JAN] ; Decanoic acid, 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl ester ; Decanoic acid, ester with 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone ; Depot haloperidol ; Haldol ; Haldol decanoas ; Haldol decanoate ; Halomonth ; Haloperidol decanoate ; Haloperidol depot .